Billionaire Mark Cuban Says 'Pharma Is the Easiest Business I've Ever Disrupted' — In a $500 Billion Industry, '1% Is A Whole Lot Of Money'

Let's be honest — nobody's walking around bragging about how great the U.S. healthcare system is. From surprise bills to mystery charges and sky-high prescription prices, it's a mess. And while most people just grit their teeth and deal with it, billionaire entrepreneur Mark Cuban is out here doing what he does best: breaking stuff that doesn't work and building something better.

Through his company Cost Plus Drugs, Cuban isn't just dipping a toe into the $500 billion pharma industry — he's cannonballing in with the goal of blowing it wide open. And according to him, it's not even that hard.

Don't Miss:

• Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!
• Invest in the future of digital engagement: Own a piece of the $100 billion Metaverse for just $500.

"Pharma is the easiest business I've ever disrupted," he said during a fireside chat with Blake Madden, founder of Hospitalogy, back in February. The conversation resurfaced in April when Madden revisited the interview and pulled the most memorable lines. But beyond the punchy quotes, Cuban laid out a vision that's equal parts common sense and rebellion — a blueprint for how he plans to pull the rug out from under an industry that's been untouchable for decades.

The playbook? Strip out the layers. Remove the games. Shine a light on the middlemen. And take the whole thing back to something that sounds more like a Norman Rockwell painting than a modern medical billing office.

"You go to the doctor, the doctor renders services, they tell you how much," Cuban said. "And if the patient can't afford it, they use a payment plan." That's the vibe he's chasing — not complicated billing codes and Byzantine networks, just price tags and pay-as-you-go options.

Trending: With shares starting at $1.52, this could be your chance to invest in the future of healthcare.

Of course, this is healthcare, so nothing's ever that simple. But Cuban says the industry's real problem isn't the complexity of medicine — it's the complexity of money. "Most of the innovations that people try to introduce are really financial engineering at some level," he said. "You know, how do I save 2% here or 3% there?"

His idea was to zoom out, look at the whole system, and then zoom all the way in — to the actual drugs, the actual prices, and the actual people getting crushed by them. Cost Plus doesn't hide what it pays. It doesn't mark up just because it can. And soon, Cuban says, it won't stop at pills — the company plans to publish direct contracting rates with hospitals and providers too.

See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — invest pre-IPO from $0.60 per share now.

That transparency, he argues, is where real disruption happens. "Just like when we published our price list and people got to see they were getting ripped off, they're going to be able to compare our direct contracting contracts."

And in a business where just a sliver of margin can mean billions in profits, he's betting that even a little clarity goes a long way. "In an industry this size, 1% is a whole lot of money," Cuban said. Which, when you look at how bloated the system's become, might be the understatement of the decade.

Read Next:

• BlackRock is calling 2025 the year of alternative assets. One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.
• ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.26/share with a $1000 minimum.